Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Apellis Pharmaceuticals Inc (NQ: APLS )

36.71 USD -0.51 (-1.37%)
Streaming Delayed Price Updated: 2:20 PM EST, Jan 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 295,278
Open 37.26
Bid (Size) 36.54 (4)
Ask (Size) 36.75 (8)
Prev. Close 37.22
Today's Range 36.69 - 38.52
52wk Range 27.50 - 73.00
Shares Outstanding 87,295,371
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Where Apellis Pharmaceuticals Stands With Analysts
Analysts have provided the following ratings for Apellis Pharmaceuticals (NASDAQ:APLS) within the last quarter: ... 
Tags Analyst Ratings APLS Market News
From Benzinga
Notable Monday Option Activity: INTC, APLS, PLCE
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Intel Corp (INTC), where a total of 202,269 contracts have traded so far, representing... 
Tags Stocks
From Market News Video

Performance

YTD
-24.73%
-24.73%
1 Month
-22.39%
-22.39%
3 Month
+16.39%
+16.39%
6 Month
-44.90%
-44.90%
1 Year
-13.91%
-13.91%

More News

Read More
APLS Crosses Above Key Moving Average Level
Tags Stocks
From Market News Video
Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder
Tags General Briefs Biotech
From Benzinga
What 9 Analyst Ratings Have To Say About Apellis Pharmaceuticals
Tags Market News APLS Analyst Ratings
From Benzinga
Investors Grab APLS Even Lower Than Its Secondary Stock Offering
Tags Stocks
From Market News Video
Analysts See 31% Gains Ahead For The Holdings of ILDR
Tags ETFs
From ETF Channel
First Week of APLS July 2022 Options Trading
Tags Stocks
From Market News Video
Analyst Ratings For Apellis Pharmaceuticals
Tags APLS Analyst Ratings Market News
From Benzinga
Notable ETF Outflow Detected - XBI, CCXI, APLS, CYTK
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
Tags News NDRA ABT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.